Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

ABSTRACT: Lung microbiota of non small-cell cancer patients

PROVIDER: PRJNA632856 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	SRR11797000_1.fastq.gz	Fastqsanger.gz
	SRR11797000_2.fastq.gz	Fastqsanger.gz
	SRR11797001_1.fastq.gz	Fastqsanger.gz
	SRR11797001_2.fastq.gz	Fastqsanger.gz
	SRR11797002_1.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 186

Similar Datasets

Postoperative circulating tumor DNA monitoring for stage I-III non-small cell lung cancer

Project description:The target sequecing vcf data of tumor and curculating tumor DNA for non-small cell lung cancer patients.

2022-05-09 | PRJEB52694 | EVA

Homo sapiens

Project description:Non Small Cell Lung Cancer

| PRJNA90997 | ENA

Homo sapiens

Project description:Circulating RNAs profile in non-small cell lung cancer patients

| PRJNA286291 | ENA

Clinical and genomic features of Chinese lung cancer patients with germline mutations

Project description:This cohort included NGS data of a panel on 1021 cancer related gene from paired cancer-normal samples of 1794 Chinese lung cancer patients, including 44 SCLC patients and 1750 non-small cell lung cancer patients. According to ACMG 2015 guideline, pathogenic germline mutations were annotated and manually verified.

2022-07-06 | PRJEB41076 | EVA

Project description:Lung microbiome of non-small cell lung cancer

| PRJNA647170 | ENA

Project description:Choice Study of Sequencing Chinese Non-Small Cell Lung Cancer Patients

| PRJEB31315 | ENA

Genomic landscape affected by allelic imbalance in the cancerization filed of normal appearing airway

Project description:Normal appearing airway samples from non-small cell lung (NSCLC) cancer patients were profiled using illumina sequencing arrays. Allelic imbalance was detected in normal-appearing large and small airway samples and affected known lung cancer driver genes.

2016-08-10 | GSE80519 | GEO

Shotgun proteomics of lung tumors and normal tumor-adjacent tissue of non-small cell lung cancer patients

Project description:Lung tumors, as well as normal tumor-adjacent (NTA) tissue of non-small cell lung cancer (NSCLC) patients, were collected and subjected label-free quantitation shotgun proteomics in data-independent mode to identify differences between the tumors and adjacent tissue. By employing in-depth proteomics, we identified several pathways that are up- or downregulated in the tumors of non-small cell lung cancer patients.

2023-11-27 | PXD046998 | Pride

Project description:Non-small Cell Lung Cancer (qRT-PCR)

| PRJNA107251 | ENA

Liu2023 - Predicting the efficacy of immune checkpoint inhibitors monotherapy in advanced non-small cell lung cancer: a machine learning method based on multidimensional data

Project description:Immunotherapy has improved the prognosis of patients with advanced non-small cell lung cancer (NSCLC), but only a small subset of patients achieved clinical benefit. The purpose of our study was to integrate multidimensional data using a machine learning method to predict the therapeutic efficacy of immune checkpoint inhibitors (ICIs) monotherapy in patients with advanced NSCLC.The authors retrospectively enrolled 112 patients with stage IIIB-IV NSCLC receiving ICIs monotherapy. The random forest (RF) algorithm was used to establish efficacy prediction models based on five different input datasets, including precontrast computed tomography (CT) radiomic data, postcontrast CT radiomic data, combination of the two CT radiomic data, clinical data, and a combination of radiomic and clinical data. The 5-fold cross-validation was used to train and test the random forest classifier. The performance of the models was assessed according to the area under the curve (AUC) in the receiver operating characteristic (ROC) curve. Among these models(RF MLP LR XGBoost), our reproduced onnx models have better performance, especially for random forest. The response variable with a value (1/0) indicates the (efficacy/inefficacy) of PD-1/PD-L1 monotherapy in patients with advanced NSCLC

2023-07-11 | BIOMD0000001074 | BioModels

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

Tweets

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data